120 related articles for article (PubMed ID: 17516844)
21. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
Gu J; Tamura M; Yamada KM
J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
[TBL] [Abstract][Full Text] [Related]
22. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
Sarver AL; Li L; Subramanian S
Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.
Yip-Schneider MT; Lin A; Marshall MS
Biochem Biophys Res Commun; 2001 Feb; 280(4):992-7. PubMed ID: 11162624
[TBL] [Abstract][Full Text] [Related]
25. WNT11 is a direct target of early growth response protein 1.
Kim J; Jung E; Ahn SS; Yeo H; Lee JY; Seo JK; Lee YH; Shin SY
BMB Rep; 2020 Dec; 53(12):628-633. PubMed ID: 32635983
[TBL] [Abstract][Full Text] [Related]
26. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor 2 mRNA expression evoked by amitriptyline involves extracellular signal-regulated kinase-dependent early growth response 1 production in rat primary cultured astrocytes.
Kajitani N; Hisaoka-Nakashima K; Okada-Tsuchioka M; Hosoi M; Yokoe T; Morioka N; Nakata Y; Takebayashi M
J Neurochem; 2015 Oct; 135(1):27-37. PubMed ID: 26183033
[TBL] [Abstract][Full Text] [Related]
28. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
29. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
30. Paradoxical induction of growth arrest and apoptosis by EGF via the up-regulation of PTEN by activating Redox factor-1/Egr-1 in human lung cancer cells.
Ryu JW; Choe SS; Ryu SH; Park EY; Lee BW; Kim TK; Ha CH; Lee SW
Oncotarget; 2017 Jan; 8(3):4181-4195. PubMed ID: 27935858
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract][Full Text] [Related]
32. PPP6C negatively regulates oncogenic ERK signaling through dephosphorylation of MEK.
Cho E; Lou HJ; Kuruvilla L; Calderwood DA; Turk BE
Cell Rep; 2021 Mar; 34(13):108928. PubMed ID: 33789117
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration.
Heering J; Erlmann P; Olayioye MA
Exp Cell Res; 2009 Sep; 315(15):2505-14. PubMed ID: 19482022
[TBL] [Abstract][Full Text] [Related]
34. PTEN is indispensable for cells to respond to MAPK inhibitors in myeloid leukemia.
Zhang J; Xiang Z; Malaviarachchi PA; Yan Y; Baltz NJ; Emanuel PD; Liu YL
Cell Signal; 2018 Oct; 50():72-79. PubMed ID: 29964149
[TBL] [Abstract][Full Text] [Related]
35. Activation of Toll-like receptor 7 regulates the expression of IFN-λ1, p53, PTEN, VEGF, TIMP-1 and MMP-9 in pancreatic cancer cells.
Wang F; Jin R; Zou BB; Li L; Cheng FW; Luo X; Geng X; Zhang SQ
Mol Med Rep; 2016 Feb; 13(2):1807-12. PubMed ID: 26718740
[TBL] [Abstract][Full Text] [Related]
36. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
37. Regulation of cell proliferation and migration by keratin19-induced nuclear import of early growth response-1 in breast cancer cells.
Ju JH; Yang W; Lee KM; Oh S; Nam K; Shim S; Shin SY; Gye MC; Chu IS; Shin I
Clin Cancer Res; 2013 Aug; 19(16):4335-46. PubMed ID: 23833298
[TBL] [Abstract][Full Text] [Related]
38. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
Reffas S; Schlegel W
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
[TBL] [Abstract][Full Text] [Related]
39. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.
Weng LP; Brown JL; Eng C
Hum Mol Genet; 2001 Mar; 10(6):599-604. PubMed ID: 11230179
[TBL] [Abstract][Full Text] [Related]
40. SDF1alpha/CXCR4 signaling, via ERKs and the transcription factor Egr1, induces expression of a 67-kDa form of glutamic acid decarboxylase in embryonic hippocampal neurons.
Luo Y; Lathia J; Mughal M; Mattson MP
J Biol Chem; 2008 Sep; 283(36):24789-800. PubMed ID: 18606818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
